annual CFI:
$792.00M-$176.00M(-18.18%)Summary
- As of today (June 22, 2025), TEVA annual cash flow from investing activities is $792.00 million, with the most recent change of -$176.00 million (-18.18%) on December 31, 2024.
- During the last 3 years, TEVA annual CFI has fallen by -$731.00 million (-48.00%).
- TEVA annual CFI is now -77.02% below its all-time high of $3.45 billion, reached on December 31, 2017.
Performance
TEVA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$201.00M-$1.00M(-0.50%)Summary
- As of today (June 22, 2025), TEVA quarterly cash flow from investing activities is $201.00 million, with the most recent change of -$1.00 million (-0.50%) on March 31, 2025.
- Over the past year, TEVA quarterly CFI has increased by +$57.00 million (+39.58%).
- TEVA quarterly CFI is now -89.49% below its all-time high of $1.91 billion, reached on December 31, 2017.
Performance
TEVA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$849.00M+$57.00M(+7.20%)Summary
- As of today (June 22, 2025), TEVA TTM cash flow from investing activities is $849.00 million, with the most recent change of +$57.00 million (+7.20%) on March 31, 2025.
- Over the past year, TEVA TTM CFI has dropped by -$82.00 million (-8.81%).
- TEVA TTM CFI is now -77.08% below its all-time high of $3.70 billion, reached on September 30, 2018.
Performance
TEVA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TEVA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.2% | +39.6% | -8.8% |
| 3 y3 years | -48.0% | +24.8% | -27.8% |
| 5 y5 years | -41.5% | -20.2% | -36.4% |
TEVA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.0% | +20.7% | -33.4% | +39.6% | -27.8% | +29.4% |
| 5 y | 5-year | -48.0% | +20.7% | -60.4% | +42.5% | -44.3% | +29.4% |
| alltime | all time | -77.0% | +102.3% | -89.5% | +100.6% | -77.1% | +102.4% |
TEVA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $201.00M(-0.5%) | $849.00M(+7.2%) |
| Dec 2024 | $792.00M(-18.2%) | $202.00M(-24.6%) | $792.00M(-11.1%) |
| Sep 2024 | - | $268.00M(+50.6%) | $891.00M(+10.4%) |
| Jun 2024 | - | $178.00M(+23.6%) | $807.00M(-13.3%) |
| Mar 2024 | - | $144.00M(-52.2%) | $931.00M(-3.8%) |
| Dec 2023 | $968.00M(+47.6%) | $301.00M(+63.6%) | $968.00M(+15.9%) |
| Sep 2023 | - | $184.00M(-39.1%) | $835.00M(+4.6%) |
| Jun 2023 | - | $302.00M(+66.9%) | $798.00M(+18.0%) |
| Mar 2023 | - | $181.00M(+7.7%) | $676.00M(+3.0%) |
| Dec 2022 | $656.00M(-56.9%) | $168.00M(+14.3%) | $656.00M(-10.6%) |
| Sep 2022 | - | $147.00M(-18.3%) | $734.00M(-16.1%) |
| Jun 2022 | - | $180.00M(+11.8%) | $875.00M(-25.6%) |
| Mar 2022 | - | $161.00M(-34.6%) | $1.18B(-22.8%) |
| Dec 2021 | $1.52B(+76.5%) | $246.00M(-14.6%) | $1.52B(+7.4%) |
| Sep 2021 | - | $288.00M(-40.1%) | $1.42B(+10.2%) |
| Jun 2021 | - | $481.00M(-5.3%) | $1.29B(+15.0%) |
| Mar 2021 | - | $508.00M(+260.3%) | $1.12B(+29.7%) |
| Dec 2020 | $863.00M(-36.3%) | $141.00M(-10.2%) | $863.00M(-25.1%) |
| Sep 2020 | - | $157.00M(-49.8%) | $1.15B(-5.5%) |
| Jun 2020 | - | $313.00M(+24.2%) | $1.22B(-8.7%) |
| Mar 2020 | - | $252.00M(-41.4%) | $1.33B(-1.5%) |
| Dec 2019 | $1.35B(-27.4%) | $430.00M(+92.0%) | $1.35B(+35.6%) |
| Sep 2019 | - | $224.00M(-47.8%) | $999.00M(-11.0%) |
| Jun 2019 | - | $429.00M(+57.7%) | $1.12B(+2.1%) |
| Mar 2019 | - | $272.00M(+267.6%) | $1.10B(-41.1%) |
| Dec 2018 | $1.87B(-45.9%) | $74.00M(-78.7%) | $1.87B(-49.6%) |
| Sep 2018 | - | $347.00M(-14.5%) | $3.70B(+7.0%) |
| Jun 2018 | - | $406.00M(-60.9%) | $3.46B(+16.6%) |
| Mar 2018 | - | $1.04B(-45.7%) | $2.97B(-13.8%) |
| Dec 2017 | $3.45B(-110.0%) | $1.91B(+1738.5%) | $3.45B(+66.3%) |
| Sep 2017 | - | $104.00M(-220.9%) | $2.07B(-106.8%) |
| Jun 2017 | - | -$86.00M(-105.7%) | -$30.33B(-0.5%) |
| Mar 2017 | - | $1.52B(+181.8%) | -$30.47B(-11.4%) |
| Dec 2016 | -$34.41B(+518.2%) | $538.00M(-101.7%) | -$34.41B(-2.4%) |
| Sep 2016 | - | -$32.30B(>+9900.0%) | -$35.24B(+1047.4%) |
| Jun 2016 | - | -$225.00M(-90.7%) | -$3.07B(-60.4%) |
| Mar 2016 | - | -$2.42B(+724.9%) | -$7.76B(+39.5%) |
| Dec 2015 | -$5.57B(+283.8%) | -$293.00M(+115.4%) | -$5.57B(-1.0%) |
| Sep 2015 | - | -$136.00M(-97.2%) | -$5.62B(-6.5%) |
| Jun 2015 | - | -$4.92B(+2145.2%) | -$6.01B(+369.2%) |
| Mar 2015 | - | -$219.00M(-36.9%) | -$1.28B(-11.7%) |
| Dec 2014 | -$1.45B(+26.4%) | -$347.00M(-34.3%) | -$1.45B(+2.2%) |
| Sep 2014 | - | -$528.00M(+182.4%) | -$1.42B(+19.2%) |
| Jun 2014 | - | -$187.00M(-51.8%) | -$1.19B(-6.2%) |
| Mar 2014 | - | -$388.00M(+22.8%) | -$1.27B(+10.6%) |
| Dec 2013 | -$1.15B(+1.1%) | -$316.00M(+5.7%) | -$1.15B(-7.5%) |
| Sep 2013 | - | -$299.00M(+12.4%) | -$1.24B(+4.2%) |
| Jun 2013 | - | -$266.00M(0.0%) | -$1.19B(-1.3%) |
| Mar 2013 | - | -$266.00M(-35.0%) | -$1.21B(+6.3%) |
| Dec 2012 | -$1.13B(-85.1%) | -$409.00M(+64.3%) | -$1.13B(-81.8%) |
| Sep 2012 | - | -$249.00M(-11.7%) | -$6.22B(-13.2%) |
| Jun 2012 | - | -$282.00M(+45.4%) | -$7.16B(+0.6%) |
| Mar 2012 | - | -$194.00M(-96.5%) | -$7.12B(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$7.60B(+39.3%) | -$5.49B(+359.9%) | -$7.60B(+226.8%) |
| Sep 2011 | - | -$1.19B(+397.5%) | -$2.33B(-62.7%) |
| Jun 2011 | - | -$240.00M(-64.5%) | -$6.23B(+7.4%) |
| Mar 2011 | - | -$676.00M(+213.0%) | -$5.80B(+6.4%) |
| Dec 2010 | -$5.46B(+495.5%) | -$216.00M(-95.8%) | -$5.46B(-0.9%) |
| Sep 2010 | - | -$5.10B(-2798.4%) | -$5.50B(+645.5%) |
| Jun 2010 | - | $189.00M(-157.6%) | -$738.00M(-33.0%) |
| Mar 2010 | - | -$328.00M(+24.7%) | -$1.10B(+20.3%) |
| Dec 2009 | -$916.00M(-77.9%) | -$263.00M(-21.7%) | -$916.00M(-79.7%) |
| Sep 2009 | - | -$336.00M(+92.0%) | -$4.51B(+4.2%) |
| Jun 2009 | - | -$175.00M(+23.2%) | -$4.33B(-1.5%) |
| Mar 2009 | - | -$142.00M(-96.3%) | -$4.39B(+6.2%) |
| Dec 2008 | -$4.14B(+205.8%) | -$3.86B(+2403.9%) | -$4.14B(+481.9%) |
| Sep 2008 | - | -$154.00M(-36.4%) | -$711.00M(-9.0%) |
| Jun 2008 | - | -$242.00M(-310.4%) | -$781.00M(+44.4%) |
| Mar 2008 | - | $115.00M(-126.7%) | -$541.00M(-60.0%) |
| Dec 2007 | -$1.35B(-66.7%) | -$430.00M(+92.0%) | -$1.35B(+52.1%) |
| Sep 2007 | - | -$224.00M(>+9900.0%) | -$889.30M(-28.3%) |
| Jun 2007 | - | -$2.00M(-99.7%) | -$1.24B(-21.0%) |
| Mar 2007 | - | -$697.00M(-2168.2%) | -$1.57B(-61.3%) |
| Dec 2006 | -$4.06B(+654.3%) | $33.70M(-105.9%) | -$4.06B(-1.7%) |
| Sep 2006 | - | -$575.20M(+73.0%) | -$4.13B(+5.5%) |
| Jun 2006 | - | -$332.50M(-89.6%) | -$3.91B(+7.0%) |
| Mar 2006 | - | -$3.18B(+8623.3%) | -$3.66B(+579.9%) |
| Dec 2005 | -$538.00M(-77.5%) | -$36.50M(-89.9%) | -$538.00M(-42.6%) |
| Sep 2005 | - | -$361.20M(+375.3%) | -$936.70M(+41.2%) |
| Jun 2005 | - | -$76.00M(+18.2%) | -$663.30M(-17.3%) |
| Mar 2005 | - | -$64.30M(-85.2%) | -$801.70M(-66.5%) |
| Dec 2004 | -$2.39B(+450.0%) | -$435.20M(+395.7%) | -$2.39B(+23.6%) |
| Sep 2004 | - | -$87.80M(-59.0%) | -$1.94B(-5.9%) |
| Jun 2004 | - | -$214.40M(-87.1%) | -$2.06B(+3.1%) |
| Mar 2004 | - | -$1.66B(-7591.4%) | -$1.99B(+358.3%) |
| Dec 2003 | -$435.10M(-34.6%) | $22.10M(-110.6%) | -$435.10M(-11.0%) |
| Sep 2003 | - | -$208.40M(+36.8%) | -$488.80M(-12.3%) |
| Jun 2003 | - | -$152.30M(+57.8%) | -$557.50M(-6.0%) |
| Mar 2003 | - | -$96.50M(+205.4%) | -$593.20M(-10.8%) |
| Dec 2002 | -$664.90M(+248.7%) | -$31.60M(-88.6%) | -$664.90M(-5.4%) |
| Sep 2002 | - | -$277.10M(+47.4%) | -$702.55M(+51.1%) |
| Jun 2002 | - | -$188.00M(+11.8%) | -$464.92M(+41.1%) |
| Mar 2002 | - | -$168.20M(+142.9%) | -$329.38M(+72.8%) |
| Dec 2001 | -$190.65M(+126.1%) | -$69.25M(+75.5%) | -$190.65M(+57.0%) |
| Sep 2001 | - | -$39.47M(-24.8%) | -$121.40M(+48.2%) |
| Jun 2001 | - | -$52.46M(+78.0%) | -$81.93M(+178.0%) |
| Mar 2001 | - | -$29.47M | -$29.47M |
| Dec 2000 | -$84.31M(-69.0%) | - | - |
| Dec 1999 | -$271.87M(+104.2%) | - | - |
| Dec 1998 | -$133.11M(+104.2%) | - | - |
| Dec 1997 | -$65.20M(-48.7%) | - | - |
| Dec 1996 | -$127.00M(-0.2%) | - | - |
| Dec 1995 | -$127.30M(+48.2%) | - | - |
| Dec 1994 | -$85.90M(+57.3%) | - | - |
| Dec 1993 | -$54.60M(+22.4%) | - | - |
| Dec 1992 | -$44.60M(-7.7%) | - | - |
| Dec 1991 | -$48.30M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
- What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
- What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cash flow from investing activities?
The current annual CFI of TEVA is $792.00M
What is the all time high annual CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cash flow from investing activities is $3.45B
What is Teva Pharmaceutical Industries Limited annual CFI year-on-year change?
Over the past year, TEVA annual cash flow from investing activities has changed by -$176.00M (-18.18%)
What is Teva Pharmaceutical Industries Limited quarterly cash flow from investing activities?
The current quarterly CFI of TEVA is $201.00M
What is the all time high quarterly CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cash flow from investing activities is $1.91B
What is Teva Pharmaceutical Industries Limited quarterly CFI year-on-year change?
Over the past year, TEVA quarterly cash flow from investing activities has changed by +$57.00M (+39.58%)
What is Teva Pharmaceutical Industries Limited TTM cash flow from investing activities?
The current TTM CFI of TEVA is $849.00M
What is the all time high TTM CFI for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cash flow from investing activities is $3.70B
What is Teva Pharmaceutical Industries Limited TTM CFI year-on-year change?
Over the past year, TEVA TTM cash flow from investing activities has changed by -$82.00M (-8.81%)